Exciting Updates from VolitionRx's Upcoming Conference Call

VolitionRx Limited Hosting Earnings Conference Call

VolitionRx Limited (NYSE AMERICAN: VNRX) is all set to engage with investors and stakeholders in an upcoming conference call. This event promises to provide crucial insights into the company's financial health and recent business developments.

Details of the Conference Call

On the horizon, the conference call is scheduled for a Friday morning at 8:30 a.m. U.S. Eastern Time. It aims to cover financial and operational results for the current quarter alongside an insightful business update. Participants will find ways to join through various methods outlined below.

Conference Call Event: VolitionRx Limited Second Quarter Earnings and Business Update Conference Call
Date: Friday, August 15, 2025
Time: 8:30 a.m. U.S. Eastern Time / 2:30 p.m. Central European Time

How to Join the Call

Individuals located in the U.S. and Canada can participate by dialing a toll-free number, while those in the U.K. and other international locations have separate dialing options to ensure inclusion. The provided conference ID will assist attendees in connecting swiftly.

U.S. & Canada Dial-in: 1-877-407-9716 (toll-free)
U.K. Dial-in: 0 800 756 3429 (toll-free)
Toll/International: 1-201-493-6779
Conference ID: 13755349

Who Will Be Speaking?

Expect to hear from prominent figures including Louise Batchelor, Group Chief Marketing & Communications Officer, joined by Cameron Reynolds, President, and Group CEO. Other executives, including the Group CFO and Chief Medical Officer, will share their insights during the call, highlighting significant developments from the quarter and future goals.

Accessing the Live Webcast and Replay

For those unable to attend the live call, a webcast link will provide audio access to the session. Moreover, a replay will be accessible for a limited period after the event, allowing even more stakeholders to benefit from the information shared and insights offered.

Replay Dial-in Numbers:
U.S. and Canada: 1-844-512-2921 (toll-free)
International: 1-412-317-6671 (toll)
Please use replay pin number 13755349.

About VolitionRx Limited

VolitionRx is recognized globally for its dedication to advancing the field of epigenetics, focusing on innovative diagnostics to enhance healthcare outcomes for both humans and animals. Their work centers around developing intuitive and cost-effective blood tests aimed at detecting various diseases, including certain cancers, thereby enabling timely medical intervention and monitoring.

The company’s research and development efforts primarily occur in Belgium, supplemented by innovation labs and offices in other locations to foster collaborative progress and breakthroughs in diagnostics.

VolitionRx is committed to ensuring earlier detection and monitoring of diseases, ultimately improving patient quality of life.

Media Inquiries

For any media inquiries, contact Louise Batchelor via email or phone for comprehensive assistance and information.

Investor Relations

Engage with Jeremy Feffer at LifeSci Advisors for investor inquiries regarding the company's performance or future directions.

Frequently Asked Questions

When is the earnings call scheduled?

The earnings call is set for Friday, August 15, 2025, at 8:30 a.m. U.S. Eastern Time.

Who are the key speakers at the conference call?

The call will feature executives including Louise Batchelor, Cameron Reynolds, and other key leaders from VolitionRx.

How can participants join the conference call?

Participants can join by dialing the provided numbers or accessing the live audio webcast via the instructions shared in the release.

What topics will be discussed during the call?

The conference will cover financial results, significant company developments, and upcoming milestones.

Where is VolitionRx focused geographically?

VolitionRx conducts research primarily in Belgium, with additional operations in the U.S. and other locations to drive innovation.

About The Author

Riley Hayes here, a financial writer and specialist committed to assisting individuals in navigating the intricate world of finance. My love is using my blog and articles to simplify complex financial ideas into understandable, doable guidance. Having worked in finance for many years, I try to give my readers the information and resources they need to make wise financial choices.

Writing for several financial blogs has let me connect with a wide range of readers, from novice investors seeking new ideas to seasoned investors. My mission is to make money interesting and approachable so you may take charge of your financial future. I appreciate you traveling with me toward success and financial literacy.

Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.